Lidocaina Cloridrato Galenica Senese

Lidocaine Hydrochloride, the active ingredient in Lidocaina Cloridrato Galenica Senese, is a local anesthetic (amide type) presented as a sterile injectable solution for intramuscular and intravenous use. It provides reversible nerve impulse blockade for procedures requiring regional or systemic analgesia in adult patients.

GNH USA supplies Lidocaina Cloridrato Galenica Senese as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and offers reliable logistics for global distribution.

Lidocaine Hydrochloride is used in clinical settings to achieve local anesthesia and to manage certain cardiac rhythm disturbances.

- Minor surgical procedures: provides local anesthesia to facilitate pain‑free operation. - Diagnostic procedures: enables painless tissue sampling or imaging studies. - Nerve block anesthesia: produces regional numbness for limb or trunk surgeries. - Ventricular arrhythmia management: stabilizes cardiac electrical activity during acute episodes.

Adverse reactions to lidocaine injection vary in frequency and severity.

Common Side Effects: - Transient numbness at the injection site. - Mild dizziness or light‑headedness. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Cardiac arrhythmias, including ventricular tachycardia. - Seizures or central nervous system toxicity.

Lidocaine should be used with careful assessment of patient-specific factors and potential drug interactions.

- Pregnancy: safety not established; use only if benefit outweighs risk. - Breastfeeding: unknown; consider potential infant exposure. - Cardiac disease: monitor for arrhythmias, especially in patients with conduction abnormalities. - Central nervous system disorders: use cautiously; risk of seizures may increase. - Concomitant medications: review for drugs that affect lidocaine metabolism. - Store below 25°C: keep in original container, protect from light and moisture.

Lidocaine may interact with several medications, requiring assessment of clinical relevance.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may potentiate cardiotoxicity. - Other local anesthetics: additive toxicity risk. - CYP1A2 or CYP3A4 inhibitors (e.g., cimetidine, erythromycin): increase plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., propranolol): may enhance bradycardia. - Calcium channel blockers (e.g., verapamil): may affect cardiac conduction. - Diuretics (e.g., furosemide): may alter plasma protein binding.